Your browser doesn't support javascript.
loading
Biallelic ZBTB11 Variants: A Neurodevelopmental Condition with Progressive Complex Movement Disorders.
Ortigoza-Escobar, Juan Darío; Zamani, Mina; Dorison, Nathalie; Sadeghian, Saeid; Azizimalamiri, Reza; Alvi, Javeria Raza; Sultan, Tipu; Galehdari, Hamid; Shariati, Gholamreza; Saberi, Alihossein; Leeuwen, Lisette; Zifarelli, Giovanni; Bauer, Peter; d'Hardemare, Vincent; Doummar, Diane; Roze, Emmanuel; Travaglini, Lorena; Nicita, Francesco; Ojea Ponce, Núria; Zahraei, Seyed Mohammadsaleh; Alabdi, Lama; Tamim, Abdullah; Hashem, Mais O; Ababneh, Faroug; Morrow, Michelle M; Curry, Cynthia; Tam, Allison; Ruedy, Jessica; Bhambhani, Vikas; Veith, Regan; Strømme, Petter; Efthymiou, Stephanie; Alkuraya, Fowzan S; Moreno-De-Luca, Andres; Burglen, Lydie; Houlden, Henry; Maroofian, Reza.
Afiliación
  • Ortigoza-Escobar JD; Movement Disorders Unit, Pediatric Neurology Department, Institut de Recerca, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
  • Zamani M; U-703 Centre for Biomedical Research on Rare Diseases (CIBER-ER), Instituto de Salud Carlos III, Barcelona, Spain.
  • Dorison N; European Reference Network for Rare Neurological Diseases (ERN-RND), Barcelona, Spain.
  • Sadeghian S; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, United Kingdom.
  • Azizimalamiri R; Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
  • Alvi JR; Narges Medical Genetics and Prenatal Diagnosis Laboratory, Ahvaz, Iran.
  • Sultan T; Unité Dyspa, Neurochirurgie Pédiatrique, Hôpital Fondation Rothschild, Paris, France.
  • Galehdari H; Department of Pediatric Neurology, Golestan Medical, Educational, and Research Centre, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Shariati G; Department of Pediatric Neurology, Golestan Medical, Educational, and Research Centre, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Saberi A; Department of Pediatric Neurology, The Children's Hospital and the University of Child Health Sciences, Lahore, Pakistan.
  • Leeuwen L; Department of Pediatric Neurology, The Children's Hospital and the University of Child Health Sciences, Lahore, Pakistan.
  • Zifarelli G; Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
  • Bauer P; Narges Medical Genetics and Prenatal Diagnosis Laboratory, Ahvaz, Iran.
  • d'Hardemare V; Department of Medical Genetics, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Doummar D; Narges Medical Genetics and Prenatal Diagnosis Laboratory, Ahvaz, Iran.
  • Roze E; Department of Medical Genetics, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Travaglini L; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Nicita F; CENTOGENE GmbH, Rostock, Germany.
  • Ojea Ponce N; CENTOGENE GmbH, Rostock, Germany.
  • Zahraei SM; Unité Dyspa, Neurochirurgie Pédiatrique, Hôpital Fondation Rothschild, Paris, France.
  • Alabdi L; AP-HP. Sorbonne Université, Service de Neuropédiatrie et Centre de Référence Neurogénétique, Hôpital Armand Trousseau, FHU I2D2, Paris, France.
  • Tamim A; Assistance Publique-Hôpitaux de Paris CHU Pitié-Salpêtrière DMU Neurosciences et Sorbonne Université, INSERM, CNRS, Institut du Cerveau, Paris, France.
  • Hashem MO; Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, IRCCS, Bambino Gesù Children's Hospital, Rome, Italy.
  • Ababneh F; Unit of Neuromuscular and Neurodegenerative Disorders, IRCCS, Bambino Gesù Children's Hospital of Rome, Rome, Italy.
  • Morrow MM; Department of Statistics, Institut de Recerca Sant Joan de Déu Barcelona, Barcelona, Spain.
  • Curry C; Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran.
  • Tam A; Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Ruedy J; Division of Genetics, Department of Pediatrics, King Abdullah Specialized Children Hospital, King Abdulaziz Medical City, MNGHA, Riyadh, Saudi Arabia.
  • Bhambhani V; King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Veith R; Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Strømme P; Division of Genetics, Department of Pediatrics, King Abdullah Specialized Children Hospital, King Abdulaziz Medical City, MNGHA, Riyadh, Saudi Arabia.
  • Efthymiou S; King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Alkuraya FS; GeneDx, Gaithersburg, Maryland, USA.
  • Moreno-De-Luca A; Department of Pediatrics, Genetic Medicine, UCSF/Fresno, Fresno, California, USA.
  • Burglen L; Division of Medical Genetics, Department of Pediatrics, University of California San Francisco, San Francisco, California, USA.
  • Houlden H; Genetics Clinic, Children's MN, Minneapolis, Minnesota, USA.
  • Maroofian R; Genetics Clinic, Children's MN, Minneapolis, Minnesota, USA.
Mov Disord ; 2024 Jun 20.
Article en En | MEDLINE | ID: mdl-38899514
ABSTRACT

BACKGROUND:

Biallelic ZBTB11 variants have previously been associated with an ultrarare subtype of autosomal recessive intellectual developmental disorder (MRT69).

OBJECTIVE:

The aim was to provide insights into the clinical and genetic characteristics of ZBTB11-related disorders (ZBTB11-RD), with a particular emphasis on progressive complex movement abnormalities.

METHODS:

Thirteen new and 16 previously reported affected individuals, ranging in age from 2 to 50 years, with biallelic ZBTB11 variants underwent clinical and genetic characterization.

RESULTS:

All patients exhibited a range of neurodevelopmental phenotypes with varying severity, encompassing ocular and neurological features. Eleven new patients presented with complex abnormal movements, including ataxia, dystonia, myoclonus, stereotypies, and tremor, and 7 new patients exhibited cataracts. Deep brain stimulation was successful in treating 1 patient with generalized progressive dystonia. Our analysis revealed 13 novel variants.

CONCLUSIONS:

This study provides additional insights into the clinical features and spectrum of ZBTB11-RD, highlighting the progressive nature of movement abnormalities in the background of neurodevelopmental phenotype. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Mov Disord Asunto de la revista: NEUROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Mov Disord Asunto de la revista: NEUROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: España